Bain Capital Public Equity Management Ii, LLC Curis Inc Transaction History

Bain Capital Public Equity Management Ii, LLC

  • $1.99 Billion
  • Q3 2024

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$2.31 - $5.13 $975,074 - $2.17 Million
-422,110 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$4.45 - $8.09 $68,093 - $123,793
-15,302 Reduced 3.5%
422,110 $2.01 Million
Q3 2021

Nov 15, 2021
SELL
$6.94 - $8.85 $207,957 - $265,190
-29,965 Reduced 6.41%
437,412 $3.43 Million
Q2 2021

Aug 16, 2021
SELL
$7.45 - $16.27 $1.64 Million - $3.59 Million
-220,500 Reduced 32.06%
467,377 $3.77 Million
Q1 2021

May 17, 2021
BUY
$8.78 - $12.8 $1.19 Million - $1.74 Million
135,876 Added 24.62%
687,877 $7.79 Million
Q4 2020

Feb 16, 2021
BUY
$1.08 - $8.2 $549,367 - $4.17 Million
508,674 Added 1174.03%
552,001 $4.52 Million
Q3 2020

Nov 16, 2020
SELL
$0.95 - $1.42 $9,245 - $13,819
-9,732 Reduced 18.34%
43,327 $51,000
Q2 2020

Aug 14, 2020
SELL
$0.63 - $1.7 $1,759 - $4,748
-2,793 Reduced 5.0%
53,059 $64,000
Q2 2019

Aug 14, 2019
BUY
$1.36 - $2.35 $75,958 - $131,252
55,852 New
55,852 $104,000

About CURIS INC

CRIS Quotes by TradingView
  • Ticker CRIS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 91,814,704
  • Market Cap $409M
  • Description
  • Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...
More about CRIS
Track This Portfolio

Track Bain Capital Public Equity Management Ii, LLC Portfolio

Follow Bain Capital Public Equity Management Ii, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bain Capital Public Equity Management Ii, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bain Capital Public Equity Management Ii, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email